27 | MucinsIBA
11/2023
-
11/2004 |
15 | Proteins (Proteins, Gene)FDA Link
01/2023
-
06/2002 |
13 | Biomarkers (Surrogate Marker)IBA
01/2023
-
06/2009 |
13 | Adenosine Triphosphate (ATP)IBA
01/2022
-
05/2003 |
12 | CytokinesIBA
11/2023
-
09/2002 |
11 | Adenosine (Adenocard)FDA LinkGeneric
01/2022
-
04/2003 |
7 | Amiloride (Midamor)FDA LinkGeneric
12/2008
-
01/2003 |
6 | RNA (Ribonucleic Acid)IBA
11/2023
-
01/2020 |
6 | Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
11/2023
-
01/2004 |
6 | Epithelial Sodium ChannelsIBA
01/2018
-
12/2004 |
5 | NucleotidesIBA
01/2017
-
08/2003 |
5 | Chloride Channels (Chloride Channel)IBA
01/2011
-
09/2002 |
4 | Phenobarbital (Luminal)FDA Link
01/2023
-
03/2005 |
4 | SmokeIBA
01/2023
-
02/2012 |
4 | Antiviral Agents (Antivirals)IBA
02/2022
-
05/2021 |
4 | Angiotensin-Converting Enzyme 2IBA
01/2022
-
01/2020 |
4 | Urea (Carbamide)FDA LinkGeneric
01/2017
-
06/2009 |
4 | SodiumIBA
01/2016
-
06/2007 |
4 | Anti-Bacterial Agents (Antibiotics)IBA
05/2012
-
02/2006 |
4 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2009
-
09/2002 |
3 | Interleukin-6 (Interleukin 6)IBA
01/2023
-
07/2003 |
3 | Glycoproteins (Glycoprotein)IBA
01/2022
-
01/2022 |
3 | Interleukin-13IBA
01/2022
-
04/2008 |
3 | Messenger RNA (mRNA)IBA
12/2020
-
10/2012 |
3 | Mucin-5BIBA
01/2019
-
11/2018 |
3 | PurinesIBA
12/2016
-
06/2009 |
3 | beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
04/2013
-
01/2006 |
3 | Adenosine Monophosphate (AMP)IBA
10/2011
-
08/2004 |
2 | N-methyl-valyl-amiclenomycin (BA 2)IBA
11/2023
-
02/2023 |
2 | Adrenal Cortex Hormones (Corticosteroids)IBA
12/2022
-
01/2019 |
2 | LigandsIBA
12/2022
-
01/2005 |
2 | Expectorants (Mucolytics)IBA
12/2022
-
01/2019 |
2 | CollagenIBA
02/2022
-
01/2022 |
2 | nintedanibIBA
02/2022
-
01/2022 |
2 | molnupiravirIBA
02/2022
-
01/2022 |
2 | AerosolsIBA
01/2022
-
07/2006 |
2 | Mucin 5ACIBA
01/2022
-
01/2019 |
2 | GoldIBA
01/2022
-
10/2011 |
2 | Detergents (Detergent)IBA
01/2022
-
05/2021 |
2 | Surface-Active Agents (Surfactants)IBA
12/2020
-
11/2020 |
2 | Transcription Factors (Transcription Factor)IBA
12/2020
-
01/2018 |
2 | Ion Channels (Ion Channel)IBA
01/2018
-
01/2013 |
2 | EnzymesIBA
12/2016
-
12/2015 |
2 | purineIBA
08/2015
-
06/2009 |
2 | Phenylalanine (L-Phenylalanine)FDA Link
04/2013
-
10/2011 |
2 | Sodium Channels (Sodium Channel)IBA
04/2012
-
11/2007 |
2 | Cyclic AMP (AMP, Cyclic)IBA
06/2009
-
08/2004 |
2 | ChitinasesIBA
04/2009
-
04/2008 |
2 | Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2005
-
08/2004 |
1 | InterleukinsIBA
11/2023 |
1 | CotinineIBA
01/2023 |
1 | NicotineFDA Link
01/2023 |
1 | Viral RNAIBA
01/2023 |
1 | hydroxycotinineIBA
01/2023 |
1 | InflammasomesIBA
01/2023 |
1 | Periodic AcidIBA
12/2022 |
1 | Alcian BlueIBA
12/2022 |
1 | ErbB Receptors (EGF Receptor)IBA
12/2022 |
1 | DNA (Deoxyribonucleic Acid)IBA
11/2022 |
1 | Peptide Hydrolases (Proteases)FDA Link
03/2022 |
1 | Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
03/2022 |
1 | tocilizumab (atlizumab)FDA Link
03/2022 |
1 | Reducing AgentsIBA
01/2022 |
1 | Complement System Proteins (Complement)IBA
01/2022 |
1 | P-2165IBA
01/2022 |
1 | Sulfhydryl Compounds (Thiols)IBA
01/2022 |
1 | Methionine (L-Methionine)FDA Link
01/2022 |
1 | Proline (L-Proline)FDA Link
01/2022 |
1 | (2R,3R,4R,5S)- 6- (((2S,3R,4R,5R)- 2,3,4,5,6- pentahydroxyhexyl)- (2- (4- (sulfanylmethyl)phenoxy)ethyl)amino)hexane- 1,2,3,4,5- pentolIBA
01/2022 |